| MGTCX | PEMGX | MGTCX / PEMGX | |
| Total Expense Ratio | 1.99 | 0.91 | 219% |
| Annual Report Gross Expense Ratio | 2.03 | 0.91 | 223% |
| Fund Existence | 12 years | 20 years | - |
| Gain YTD | 7.134 | 2.065 | 346% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 139M | 31.6B | 0% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -3.01 | -7.41 | 41% |
| Returns for 3 years | 42.56 | 32.06 | 133% |
| Returns for 5 years | -28.72 | 25.07 | -115% |
| Returns for 10 years | -20.41 | 94.30 | -22% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FTXH | 32.75 | 0.38 | +1.18% |
| First Trust Nasdaq Pharmaceuticals ETF | |||
| AIRR | 98.68 | 1.01 | +1.03% |
| First Trust RBA Amer Indl RenaisTM ETF | |||
| VLU | 210.46 | 1.45 | +0.69% |
| State Street® SPDR® S&P® 1500 ValTiltETF | |||
| IHYF | 22.67 | 0.05 | +0.22% |
| Invesco High Yield Bond Factor ETF | |||
| CPRJ | 26.67 | 0.05 | +0.20% |
| Calamos Russell 2000 Str Alt Prt ETF-Jul | |||